Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO8881 | Centipeda minima | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO21339 | Upuna borneensis | Species | Dipterocarpaceae | Eukaryota | UNPD* | |||
NPO1807 | Senecio macrocephalus | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO8493 | Capraria biflora | Species | Scrophulariaceae | Eukaryota | UNPD* | |||
NPO8239 | Mentha timija | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO11075 | Aglaia tomentosa | Species | Meliaceae | Eukaryota | UNPD* | |||
NPO18405 | Trichoderma avellaneum | Species | Hypocreaceae | Eukaryota | UNPD* | |||
NPO10032 | Backhousia citriodora | Species | Myrtaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 2328.1 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 2818.4 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT2741 | Individual Protein | Pyruvate kinase | Leishmania mexicana | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 2233.4 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 12990 | nM | PubChem BioAssay data set | |
NPT365 | Individual Protein | NAD(P)H dehydrogenase [quinone] 1 | Mus musculus | Ratio | = | 0.8 | 21105712 | |
NPT2 | Others | Unspecified | Inhibition | = | 16 | % | 21105712 | |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 12.5 | % | 21105712 |
NPT366 | Individual Protein | Quinone reductase 2 | Homo sapiens | Inhibition | = | 90 | % | 21105712 |
NPT366 | Individual Protein | Quinone reductase 2 | Homo sapiens | IC50 | = | 15300 | nM | 21105712 |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 112201.8 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 8275.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT165 | Cell Line | HeLa | Homo sapiens | AC50 | = | 73519 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | = | 370 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | = | 850 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 13115.4 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 16944.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC40 | = | 4.107 | nM | PubChem BioAssay data set | |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC285635 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9545 | High Similarity | NPC258773 |
0.929 | High Similarity | NPC1527 |
0.9013 | High Similarity | NPC36168 |
0.878 | High Similarity | NPC118776 |
0.8471 | Intermediate Similarity | NPC110741 |
0.8375 | Intermediate Similarity | NPC120798 |
0.8323 | Intermediate Similarity | NPC79911 |
0.8137 | Intermediate Similarity | NPC26850 |
0.8072 | Intermediate Similarity | NPC476518 |
0.8024 | Intermediate Similarity | NPC121658 |
0.8024 | Intermediate Similarity | NPC14651 |
0.7976 | Intermediate Similarity | NPC111624 |
0.795 | Intermediate Similarity | NPC26872 |
0.7929 | Intermediate Similarity | NPC95898 |
0.7901 | Intermediate Similarity | NPC315957 |
0.7857 | Intermediate Similarity | NPC470586 |
0.7771 | Intermediate Similarity | NPC177404 |
0.7701 | Intermediate Similarity | NPC308392 |
0.7701 | Intermediate Similarity | NPC161887 |
0.7701 | Intermediate Similarity | NPC266551 |
0.7701 | Intermediate Similarity | NPC219963 |
0.7688 | Intermediate Similarity | NPC471736 |
0.7627 | Intermediate Similarity | NPC314573 |
0.7581 | Intermediate Similarity | NPC223427 |
0.7571 | Intermediate Similarity | NPC20249 |
0.7568 | Intermediate Similarity | NPC232727 |
0.7543 | Intermediate Similarity | NPC478023 |
0.7514 | Intermediate Similarity | NPC176538 |
0.7514 | Intermediate Similarity | NPC62069 |
0.75 | Intermediate Similarity | NPC134079 |
0.7486 | Intermediate Similarity | NPC66083 |
0.7486 | Intermediate Similarity | NPC206251 |
0.7486 | Intermediate Similarity | NPC74382 |
0.7474 | Intermediate Similarity | NPC174672 |
0.7446 | Intermediate Similarity | NPC474188 |
0.7444 | Intermediate Similarity | NPC224327 |
0.7435 | Intermediate Similarity | NPC123976 |
0.7435 | Intermediate Similarity | NPC167860 |
0.7432 | Intermediate Similarity | NPC131017 |
0.7416 | Intermediate Similarity | NPC84478 |
0.7414 | Intermediate Similarity | NPC312872 |
0.7412 | Intermediate Similarity | NPC118511 |
0.7396 | Intermediate Similarity | NPC25899 |
0.7382 | Intermediate Similarity | NPC174758 |
0.7371 | Intermediate Similarity | NPC288943 |
0.736 | Intermediate Similarity | NPC176127 |
0.7351 | Intermediate Similarity | NPC267928 |
0.7333 | Intermediate Similarity | NPC288445 |
0.733 | Intermediate Similarity | NPC82548 |
0.733 | Intermediate Similarity | NPC283152 |
0.7283 | Intermediate Similarity | NPC226202 |
0.7279 | Intermediate Similarity | NPC143156 |
0.7273 | Intermediate Similarity | NPC86078 |
0.7251 | Intermediate Similarity | NPC48192 |
0.7247 | Intermediate Similarity | NPC222592 |
0.7247 | Intermediate Similarity | NPC168486 |
0.7238 | Intermediate Similarity | NPC204385 |
0.7234 | Intermediate Similarity | NPC19872 |
0.7234 | Intermediate Similarity | NPC121772 |
0.7234 | Intermediate Similarity | NPC329747 |
0.7222 | Intermediate Similarity | NPC193267 |
0.7222 | Intermediate Similarity | NPC213530 |
0.7211 | Intermediate Similarity | NPC162484 |
0.7182 | Intermediate Similarity | NPC42591 |
0.7173 | Intermediate Similarity | NPC285558 |
0.7158 | Intermediate Similarity | NPC199277 |
0.7158 | Intermediate Similarity | NPC135887 |
0.7157 | Intermediate Similarity | NPC274982 |
0.7135 | Intermediate Similarity | NPC472111 |
0.7128 | Intermediate Similarity | NPC72211 |
0.7113 | Intermediate Similarity | NPC469589 |
0.7112 | Intermediate Similarity | NPC70259 |
0.7111 | Intermediate Similarity | NPC206201 |
0.7094 | Intermediate Similarity | NPC227908 |
0.7074 | Intermediate Similarity | NPC243834 |
0.7074 | Intermediate Similarity | NPC70956 |
0.7068 | Intermediate Similarity | NPC295898 |
0.7062 | Intermediate Similarity | NPC287208 |
0.7059 | Intermediate Similarity | NPC205934 |
0.7059 | Intermediate Similarity | NPC43787 |
0.7053 | Intermediate Similarity | NPC329793 |
0.7053 | Intermediate Similarity | NPC11017 |
0.7043 | Intermediate Similarity | NPC114335 |
0.7043 | Intermediate Similarity | NPC141915 |
0.7043 | Intermediate Similarity | NPC280964 |
0.7043 | Intermediate Similarity | NPC195268 |
0.7043 | Intermediate Similarity | NPC133140 |
0.7031 | Intermediate Similarity | NPC245816 |
0.7031 | Intermediate Similarity | NPC476138 |
0.7027 | Intermediate Similarity | NPC471593 |
0.7021 | Intermediate Similarity | NPC13880 |
0.701 | Intermediate Similarity | NPC193777 |
0.7005 | Intermediate Similarity | NPC79293 |
0.7005 | Intermediate Similarity | NPC279401 |
0.7 | Intermediate Similarity | NPC18487 |
0.7 | Intermediate Similarity | NPC287437 |
0.6995 | Remote Similarity | NPC36229 |
0.6995 | Remote Similarity | NPC16452 |
0.6995 | Remote Similarity | NPC476581 |
0.698 | Remote Similarity | NPC310118 |
0.698 | Remote Similarity | NPC60621 |
0.6973 | Remote Similarity | NPC296527 |
0.697 | Remote Similarity | NPC471080 |
0.697 | Remote Similarity | NPC469592 |
0.697 | Remote Similarity | NPC60553 |
0.6966 | Remote Similarity | NPC474409 |
0.6939 | Remote Similarity | NPC185782 |
0.6939 | Remote Similarity | NPC201697 |
0.6935 | Remote Similarity | NPC76748 |
0.6927 | Remote Similarity | NPC267423 |
0.6927 | Remote Similarity | NPC476044 |
0.6919 | Remote Similarity | NPC264176 |
0.6919 | Remote Similarity | NPC472098 |
0.6915 | Remote Similarity | NPC84853 |
0.6911 | Remote Similarity | NPC476578 |
0.6911 | Remote Similarity | NPC476582 |
0.6911 | Remote Similarity | NPC4071 |
0.6906 | Remote Similarity | NPC472168 |
0.6905 | Remote Similarity | NPC161292 |
0.69 | Remote Similarity | NPC148183 |
0.69 | Remote Similarity | NPC152768 |
0.6898 | Remote Similarity | NPC92111 |
0.6891 | Remote Similarity | NPC291535 |
0.6891 | Remote Similarity | NPC475112 |
0.6891 | Remote Similarity | NPC475085 |
0.6888 | Remote Similarity | NPC470931 |
0.6888 | Remote Similarity | NPC475910 |
0.6882 | Remote Similarity | NPC242928 |
0.6881 | Remote Similarity | NPC17565 |
0.6875 | Remote Similarity | NPC234197 |
0.6869 | Remote Similarity | NPC208284 |
0.6865 | Remote Similarity | NPC61350 |
0.6839 | Remote Similarity | NPC31930 |
0.6834 | Remote Similarity | NPC26679 |
0.6834 | Remote Similarity | NPC48353 |
0.6832 | Remote Similarity | NPC469594 |
0.6831 | Remote Similarity | NPC474798 |
0.6829 | Remote Similarity | NPC122436 |
0.6826 | Remote Similarity | NPC470394 |
0.6826 | Remote Similarity | NPC470404 |
0.6826 | Remote Similarity | NPC470403 |
0.6825 | Remote Similarity | NPC307963 |
0.6823 | Remote Similarity | NPC187558 |
0.6818 | Remote Similarity | NPC471304 |
0.6812 | Remote Similarity | NPC110151 |
0.6809 | Remote Similarity | NPC469390 |
0.68 | Remote Similarity | NPC264782 |
0.6796 | Remote Similarity | NPC473432 |
0.6788 | Remote Similarity | NPC477019 |
0.6786 | Remote Similarity | NPC476106 |
0.6786 | Remote Similarity | NPC470164 |
0.6786 | Remote Similarity | NPC323345 |
0.6782 | Remote Similarity | NPC116573 |
0.6782 | Remote Similarity | NPC305984 |
0.6779 | Remote Similarity | NPC314954 |
0.6769 | Remote Similarity | NPC200836 |
0.6754 | Remote Similarity | NPC251090 |
0.6751 | Remote Similarity | NPC4687 |
0.6751 | Remote Similarity | NPC249583 |
0.675 | Remote Similarity | NPC202768 |
0.675 | Remote Similarity | NPC112206 |
0.675 | Remote Similarity | NPC202605 |
0.675 | Remote Similarity | NPC296482 |
0.675 | Remote Similarity | NPC53069 |
0.6749 | Remote Similarity | NPC197141 |
0.6748 | Remote Similarity | NPC65277 |
0.6746 | Remote Similarity | NPC470395 |
0.6744 | Remote Similarity | NPC124300 |
0.6744 | Remote Similarity | NPC153769 |
0.6735 | Remote Similarity | NPC475070 |
0.6733 | Remote Similarity | NPC8022 |
0.6733 | Remote Similarity | NPC470799 |
0.6731 | Remote Similarity | NPC187145 |
0.6721 | Remote Similarity | NPC88363 |
0.6721 | Remote Similarity | NPC72980 |
0.6716 | Remote Similarity | NPC478074 |
0.6716 | Remote Similarity | NPC162530 |
0.6716 | Remote Similarity | NPC250448 |
0.6713 | Remote Similarity | NPC316756 |
0.6713 | Remote Similarity | NPC291609 |
0.6703 | Remote Similarity | NPC212535 |
0.6701 | Remote Similarity | NPC300156 |
0.6701 | Remote Similarity | NPC45190 |
0.6699 | Remote Similarity | NPC280272 |
0.6685 | Remote Similarity | NPC478032 |
0.6684 | Remote Similarity | NPC53144 |
0.6683 | Remote Similarity | NPC472099 |
0.6683 | Remote Similarity | NPC128115 |
0.6683 | Remote Similarity | NPC470549 |
0.6682 | Remote Similarity | NPC30540 |
0.6682 | Remote Similarity | NPC469554 |
0.6667 | Remote Similarity | NPC284559 |
0.6667 | Remote Similarity | NPC313189 |
0.6667 | Remote Similarity | NPC96321 |
0.6667 | Remote Similarity | NPC477888 |
0.6667 | Remote Similarity | NPC473041 |
0.6667 | Remote Similarity | NPC171409 |
0.6667 | Remote Similarity | NPC96405 |
0.6667 | Remote Similarity | NPC46561 |
0.6667 | Remote Similarity | NPC194967 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC285635 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7901 | Intermediate Similarity | NPD1739 | Approved |
0.7901 | Intermediate Similarity | NPD1740 | Approved |
0.7735 | Intermediate Similarity | NPD1622 | Discontinued |
0.773 | Intermediate Similarity | NPD4795 | Phase 2 |
0.768 | Intermediate Similarity | NPD774 | Phase 3 |
0.7594 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7513 | Intermediate Similarity | NPD5658 | Approved |
0.7487 | Intermediate Similarity | NPD2540 | Clinical (unspecified phase) |
0.7486 | Intermediate Similarity | NPD3920 | Phase 2 |
0.7449 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7432 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.7337 | Intermediate Similarity | NPD1602 | Discontinued |
0.7308 | Intermediate Similarity | NPD2410 | Phase 2 |
0.7303 | Intermediate Similarity | NPD4204 | Approved |
0.7303 | Intermediate Similarity | NPD4203 | Approved |
0.7296 | Intermediate Similarity | NPD1744 | Approved |
0.7243 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD4724 | Clinical (unspecified phase) |
0.7228 | Intermediate Similarity | NPD4372 | Phase 1 |
0.7181 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7164 | Intermediate Similarity | NPD6306 | Phase 2 |
0.7127 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.7043 | Intermediate Similarity | NPD3923 | Approved |
0.7043 | Intermediate Similarity | NPD3921 | Approved |
0.7043 | Intermediate Similarity | NPD3924 | Approved |
0.7043 | Intermediate Similarity | NPD3922 | Approved |
0.7027 | Intermediate Similarity | NPD4081 | Clinical (unspecified phase) |
0.7011 | Intermediate Similarity | NPD6393 | Clinical (unspecified phase) |
0.701 | Intermediate Similarity | NPD7222 | Phase 2 |
0.701 | Intermediate Similarity | NPD1603 | Discontinued |
0.6971 | Remote Similarity | NPD2472 | Approved |
0.6971 | Remote Similarity | NPD2471 | Approved |
0.6968 | Remote Similarity | NPD4418 | Discontinued |
0.6959 | Remote Similarity | NPD3003 | Approved |
0.6957 | Remote Similarity | NPD7284 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD3440 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD565 | Phase 2 |
0.6915 | Remote Similarity | NPD1304 | Clinical (unspecified phase) |
0.6911 | Remote Similarity | NPD1768 | Approved |
0.6893 | Remote Similarity | NPD6872 | Clinical (unspecified phase) |
0.6891 | Remote Similarity | NPD5669 | Clinical (unspecified phase) |
0.6884 | Remote Similarity | NPD2314 | Clinical (unspecified phase) |
0.6884 | Remote Similarity | NPD2772 | Clinical (unspecified phase) |
0.6881 | Remote Similarity | NPD7194 | Discontinued |
0.6878 | Remote Similarity | NPD6251 | Discontinued |
0.6878 | Remote Similarity | NPD6590 | Discontinued |
0.6878 | Remote Similarity | NPD6491 | Clinical (unspecified phase) |
0.6878 | Remote Similarity | NPD1951 | Clinical (unspecified phase) |
0.6869 | Remote Similarity | NPD3570 | Phase 2 |
0.6869 | Remote Similarity | NPD6573 | Phase 3 |
0.6869 | Remote Similarity | NPD6572 | Phase 2 |
0.6868 | Remote Similarity | NPD2601 | Approved |
0.6868 | Remote Similarity | NPD2599 | Approved |
0.6868 | Remote Similarity | NPD2600 | Approved |
0.6863 | Remote Similarity | NPD1954 | Phase 1 |
0.6847 | Remote Similarity | NPD5070 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD6550 | Discontinued |
0.6837 | Remote Similarity | NPD7452 | Approved |
0.6837 | Remote Similarity | NPD7453 | Approved |
0.6832 | Remote Similarity | NPD2440 | Phase 3 |
0.6832 | Remote Similarity | NPD2441 | Approved |
0.6828 | Remote Similarity | NPD1033 | Clinical (unspecified phase) |
0.6828 | Remote Similarity | NPD1034 | Phase 3 |
0.6825 | Remote Similarity | NPD1038 | Approved |
0.6811 | Remote Similarity | NPD2762 | Phase 2 |
0.6811 | Remote Similarity | NPD4889 | Approved |
0.6806 | Remote Similarity | NPD2952 | Discontinued |
0.6806 | Remote Similarity | NPD5488 | Discontinued |
0.6802 | Remote Similarity | NPD2816 | Clinical (unspecified phase) |
0.6802 | Remote Similarity | NPD5863 | Clinical (unspecified phase) |
0.6796 | Remote Similarity | NPD4354 | Approved |
0.6791 | Remote Similarity | NPD5802 | Phase 2 |
0.678 | Remote Similarity | NPD7221 | Approved |
0.678 | Remote Similarity | NPD7219 | Approved |
0.6779 | Remote Similarity | NPD1474 | Approved |
0.6777 | Remote Similarity | NPD3838 | Phase 3 |
0.6774 | Remote Similarity | NPD5256 | Discontinued |
0.6772 | Remote Similarity | NPD6569 | Phase 2 |
0.6769 | Remote Similarity | NPD6991 | Approved |
0.6766 | Remote Similarity | NPD5417 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD5903 | Approved |
0.6766 | Remote Similarity | NPD5902 | Approved |
0.6754 | Remote Similarity | NPD3478 | Clinical (unspecified phase) |
0.6754 | Remote Similarity | NPD3477 | Phase 2 |
0.675 | Remote Similarity | NPD3816 | Phase 1 |
0.675 | Remote Similarity | NPD3815 | Phase 1 |
0.6747 | Remote Similarity | NPD9470 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD3562 | Approved |
0.6744 | Remote Similarity | NPD2882 | Phase 1 |
0.6744 | Remote Similarity | NPD3563 | Approved |
0.6744 | Remote Similarity | NPD3564 | Approved |
0.6739 | Remote Similarity | NPD3386 | Phase 2 |
0.6739 | Remote Similarity | NPD7414 | Clinical (unspecified phase) |
0.6736 | Remote Similarity | NPD2151 | Approved |
0.673 | Remote Similarity | NPD848 | Approved |
0.673 | Remote Similarity | NPD849 | Approved |
0.673 | Remote Similarity | NPD850 | Approved |
0.6719 | Remote Similarity | NPD4673 | Phase 2 |
0.6716 | Remote Similarity | NPD4457 | Phase 2 |
0.6715 | Remote Similarity | NPD6246 | Approved |
0.6713 | Remote Similarity | NPD1941 | Approved |
0.6713 | Remote Similarity | NPD7067 | Approved |
0.6713 | Remote Similarity | NPD7068 | Approved |
0.6702 | Remote Similarity | NPD3810 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD4305 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD6150 | Discontinued |
0.67 | Remote Similarity | NPD6567 | Clinical (unspecified phase) |
0.6684 | Remote Similarity | NPD2917 | Approved |
0.6684 | Remote Similarity | NPD9542 | Approved |
0.6667 | Remote Similarity | NPD4072 | Approved |
0.6667 | Remote Similarity | NPD4071 | Approved |
0.6667 | Remote Similarity | NPD8117 | Approved |
0.6667 | Remote Similarity | NPD8116 | Phase 3 |
0.6667 | Remote Similarity | NPD5512 | Phase 3 |
0.6667 | Remote Similarity | NPD1900 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD8512 | Phase 3 |
0.6667 | Remote Similarity | NPD1392 | Approved |
0.665 | Remote Similarity | NPD4039 | Approved |
0.665 | Remote Similarity | NPD4038 | Approved |
0.665 | Remote Similarity | NPD4037 | Approved |
0.665 | Remote Similarity | NPD4122 | Approved |
0.665 | Remote Similarity | NPD32 | Approved |
0.665 | Remote Similarity | NPD31 | Approved |
0.665 | Remote Similarity | NPD4036 | Approved |
0.665 | Remote Similarity | NPD4033 | Approved |
0.665 | Remote Similarity | NPD4035 | Approved |
0.665 | Remote Similarity | NPD4034 | Approved |
0.665 | Remote Similarity | NPD8510 | Clinical (unspecified phase) |
0.6649 | Remote Similarity | NPD2749 | Discontinued |
0.6649 | Remote Similarity | NPD4548 | Discontinued |
0.6648 | Remote Similarity | NPD1923 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD9595 | Approved |
0.6647 | Remote Similarity | NPD9596 | Approved |
0.6647 | Remote Similarity | NPD1305 | Clinical (unspecified phase) |
0.6635 | Remote Similarity | NPD4996 | Approved |
0.6635 | Remote Similarity | NPD4995 | Approved |
0.6633 | Remote Similarity | NPD7671 | Approved |
0.6633 | Remote Similarity | NPD7672 | Approved |
0.6633 | Remote Similarity | NPD6208 | Discontinued |
0.6632 | Remote Similarity | NPD2334 | Discontinued |
0.6632 | Remote Similarity | NPD6988 | Phase 1 |
0.6631 | Remote Similarity | NPD6344 | Clinical (unspecified phase) |
0.663 | Remote Similarity | NPD1503 | Clinical (unspecified phase) |
0.663 | Remote Similarity | NPD1078 | Clinical (unspecified phase) |
0.6623 | Remote Similarity | NPD254 | Approved |
0.6618 | Remote Similarity | NPD6209 | Approved |
0.6617 | Remote Similarity | NPD5416 | Discontinued |
0.6617 | Remote Similarity | NPD4502 | Phase 2 |
0.6615 | Remote Similarity | NPD4396 | Clinical (unspecified phase) |
0.6605 | Remote Similarity | NPD7729 | Clinical (unspecified phase) |
0.6604 | Remote Similarity | NPD7705 | Clinical (unspecified phase) |
0.6603 | Remote Similarity | NPD7674 | Phase 3 |
0.6603 | Remote Similarity | NPD7426 | Phase 1 |
0.6603 | Remote Similarity | NPD7675 | Phase 3 |
0.6603 | Remote Similarity | NPD1907 | Phase 3 |
0.6603 | Remote Similarity | NPD7676 | Clinical (unspecified phase) |
0.6591 | Remote Similarity | NPD9574 | Clinical (unspecified phase) |
0.6588 | Remote Similarity | NPD4925 | Approved |
0.6585 | Remote Similarity | NPD6985 | Discontinued |
0.6585 | Remote Similarity | NPD5632 | Approved |
0.6582 | Remote Similarity | NPD6592 | Clinical (unspecified phase) |
0.6576 | Remote Similarity | NPD3503 | Approved |
0.6576 | Remote Similarity | NPD3504 | Approved |
0.6576 | Remote Similarity | NPD6159 | Phase 2 |
0.6573 | Remote Similarity | NPD6494 | Phase 2 |
0.6571 | Remote Similarity | NPD1906 | Approved |
0.6566 | Remote Similarity | NPD5628 | Clinical (unspecified phase) |
0.6566 | Remote Similarity | NPD3397 | Phase 2 |
0.6562 | Remote Similarity | NPD6046 | Clinical (unspecified phase) |
0.6559 | Remote Similarity | NPD7867 | Phase 1 |
0.6556 | Remote Similarity | NPD308 | Approved |
0.6554 | Remote Similarity | NPD6060 | Clinical (unspecified phase) |
0.6553 | Remote Similarity | NPD3875 | Discontinued |
0.6552 | Remote Similarity | NPD6158 | Phase 2 |
0.6552 | Remote Similarity | NPD6476 | Clinical (unspecified phase) |
0.6548 | Remote Similarity | NPD7752 | Approved |
0.6548 | Remote Similarity | NPD7753 | Approved |
0.6546 | Remote Similarity | NPD4899 | Clinical (unspecified phase) |
0.6542 | Remote Similarity | NPD6963 | Approved |
0.6542 | Remote Similarity | NPD6964 | Approved |
0.6541 | Remote Similarity | NPD1620 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD5680 | Clinical (unspecified phase) |
0.6535 | Remote Similarity | NPD4131 | Phase 3 |
0.6535 | Remote Similarity | NPD3939 | Suspended |
0.6533 | Remote Similarity | NPD6207 | Discovery |
0.6533 | Remote Similarity | NPD6245 | Phase 2 |
0.6533 | Remote Similarity | NPD3842 | Clinical (unspecified phase) |
0.6528 | Remote Similarity | NPD3395 | Approved |
0.6528 | Remote Similarity | NPD3396 | Approved |
0.6526 | Remote Similarity | NPD4021 | Phase 2 |
0.6516 | Remote Similarity | NPD8324 | Phase 2 |
0.6515 | Remote Similarity | NPD5144 | Discontinued |
0.6514 | Remote Similarity | NPD789 | Phase 2 |
0.6508 | Remote Similarity | NPD4375 | Approved |
0.6502 | Remote Similarity | NPD6202 | Discontinued |
0.65 | Remote Similarity | NPD2782 | Approved |
0.65 | Remote Similarity | NPD2780 | Approved |
0.6498 | Remote Similarity | NPD2921 | Clinical (unspecified phase) |
0.6495 | Remote Similarity | NPD26 | Approved |
PubChem CID   | 235279 |
ChEMBL   | CHEMBL1420181 |
ZINC   |
Molecular Weight:   | 210.08 |
ALogP:   | -0.0518 |
MLogP:   | 2.56 |
XLogP:   | 3.164 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 35.01 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 16 |